一 | CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。 慧聚班本 共筑童梦 班本课程交流会 虞永平教授强调，课程的研究和实践应该以班级为基点，从而让班级成为实施幼儿园课程的主阵地。
二 | 2024年12月9日，我园为期一个月的班本课程已结束，在教学部门的组织下，全园老师齐聚四楼会议室，分享自己的收获和思考，进一步助推班本课程的深入开展。
三 | 在展示中交流 各班班主任老师从课程起源、实施过程、收获和反思等方面对班本课程进行了详细叙述。如大一班《柚子的旅行》以自然探索为主题，带领孩子们走进大自然，观察动植物的生长变化；中一班《幸“孕”之旅》以生命教育为切入点，让孩子们感受人体文化的魅力；中二班《人民币的奥秘》以人民币为载体，培养孩子们的探索精神……一个个生动的案例，充分展现了孩子的学习探究能力，老师“退位”后的教育智慧和孩子们带来的惊喜。 大一班《柚子的旅行》 大二班《我的名字》 中一班《幸“孕”之旅》 中二班《人民币的奥秘》 小一班《秋天，你好》 小二班《你好，秋天》 专业引领 积蓄成长 在年级组长、教研主任的点评后，园长屈慧就本次班本课程进行了专业引领，并指出，这次班本课程的开展，以尊重幼儿发展规律为基，助推幼儿深度学习为实，做到眼里有孩子，心中有尺度，让教育在实践生活中自然发生，充分激发了幼儿的学习兴趣和积极性，对于保教质量的提升起到了良好作用。在今后的开展中要注意课程内容的选择、教学方法与手段的创新、教育资源的整合与利用；希望大家总结经验，反思不足，更好地促进幼儿全面发展。 “一日生活皆课程。
四 | ”在本次班本课程的基础上，我们将继续探究适合幼儿的课程，提升我园的保教质量。 END # 扫码关注我们 图文：黄思婷 张娜 编辑：陶慈平 一审：唐代凯 二审：严 珊 三审：屈 慧。
Current article:http://3x7.chenzhuaigecoupuhongyuntuizei.sbs/news/20260826_648.html
Published on:14:17:50
